Respected Neuropathologist Appointed New Editor-in-Chief of the American
Journal of Pathology
PHILADELPHIA, January 3, 2013
PHILADELPHIA, January 3, 2013 /PRNewswire/ --
The editorial leadership of The American Journal of Pathology ( AJP ) passed
to the direction of esteemed neuropathologist Kevin A. Roth, M.D., Ph.D. on
January 1, 2013.
Dr. Roth holds the Robert and Ruth Anderson Endowed Chair in Pathology at the
University of Alabama at Birmingham (UAB). Involved in experimental pathology
research for nearly 30 years, he published his first paper in AJP while an
M.D., Ph.D. student at Stanford University. Dr. Roth also possesses extensive
editorial experience, having served as an Associate Editor for AJP since 2003
and as Editor-in-Chief of the Journal of Histochemistry and Cytochemistry from
2006 to 2010.
The AJP is the leading global forum for reporting quality original research on
cellular and molecular mechanisms of disease. With over 100 years of history,
the Journal is widely read by the pathology community and garners over 30,000
citations to its articles each year (Source: 2011 Journal Citation Reports ).
Notably, Dr. Roth is also currently serving as Special Editor of the AJP
Centennial Project, a special review series to celebrate the centennial of the
American Society for Investigative Pathology (ASIP), which owns AJP .
Dr. Roth has served as a Councilor for ASIP from 2010 to 2012, and is
currently the ASIP Vice President. His term as ASIP President begins in 2014.
Regarding his editorial appointment, Dr. Roth stated, "It is a special honor
to be named the new Editor-in-Chief of The American Journal of Pathology in
this centenary year. AJP , the official journal of this esteemed society
[ASIP], has historically been one of the most prestigious and frequently cited
journals in the field of pathology, and it is my intent to enhance further the
quality and recognition of the Journal."
Dr. Roth completed his postdoctoral training at Washington University, where
he rose to professor in the Division of Neuropathology, Department of
Pathology and Immunology, and in the Department of Molecular Biology and
Pharmacology. Dr. Roth moved to UAB in 2002 and served as Director of the
Division of Neuropathology until his appointment as Chair of Pathology in
Dr. Roth, a renowned researcher on the molecular regulation of neuronal cell
death, was the founding director of the UAB Comprehensive Neuroscience Center,
an interdisciplinary collaboration for neuroscience research, clinical care,
and education. The long-term goals of Dr. Roth's own research are to
understand the role of cell death in normal nervous system development and its
significance in neuropathological conditions including nervous system
AJP , published by Elsevier, is owned by and is the official journal of ASIP.
ASIP's Executive Officer, Mark E. Sobel, M.D., Ph.D., summarized ASIP's
selection of Dr. Roth by saying, "Dr. Roth is well recognized within the
academic pathology community as well as the broad discipline of experimental
biology, from which AJP draws its authors. Dr. Roth has chosen ASIP Past
President and fellow AJP Associate Editor Martha Furie, Ph.D., Professor in
the Center for Infectious Diseases at Stony Brook University, as his Senior
Associate Editor. With the appointments of Drs. Roth and Furie, the Society
leadership looks forward with excitement to what this team will bring to the
editorial direction of ASIP's flagship journal, AJP , ensuring a synergistic
relationship between the Journal and the Society."
Jay M. McDonald, M.D., himself former UAB Chair of Pathology (1990 to 2008)
and Editor-in-Chief of AJP (2003 to 2008), praised ASIP's choice: "Dr. Roth is
an outstanding academic pathologist, excelling in research, service, and
teaching. He will be an outstanding Editor-in-Chief for AJP ."
About The American Society for Investigative Pathology
The American Society for Investigative Pathology (ASIP) is a society of
biomedical scientists who investigate mechanisms of disease. Investigative
pathology is an integrative discipline that links the presentation of disease
in the whole organism to its fundamental cellular and molecular mechanisms. It
uses a variety of structural, functional, and genetic techniques and
ultimately applies research findings to the diagnosis and treatment of
diseases. ASIP advocates for the practice of investigative pathology and
fosters the professional career development and education of its members. (
About The American Journal of Pathology
The American Journal of Pathology ( http://ajp.amjpathol.org ), official
journal of the American Society for Investigative Pathology, seeks to publish
high-quality, original papers on the cellular and molecular biology of
disease. The editors accept manuscripts that advance basic and translational
knowledge of the pathogenesis, classification, diagnosis, and mechanisms of
disease, without preference for a specific analytic method. High priority is
given to studies on human disease and relevant experimental models using
cellular, molecular, animal, biological, chemical, and immunological
approaches in conjunction with morphology.
The leading global forum for reporting quality original research on cellular
and molecular mechanisms of disease, The American Journal of Pathology is the
most highly cited journal in Pathology - over 38,000 cites in 2011 - with an
Impact Factor of 4.890 according to 2011 Journal Citation Reports ^® Thomson
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).
For more information on Dr. Roth, please contact Meghan Davis, Media
Specialist, University of Alabama at Birmingham. Phone: +1-205-934-3884;
e-mail: firstname.lastname@example.org .
For more information on The American Journal of Pathology or the American
Society for Investigative Pathology, please contact Dr. Audra E. Cox, Managing
Editor, The American Journal of Pathology, 9650 Rockville Pike, Bethesda MD
20814. Phone: +1-301-634-7409; Fax: +1-301-634-7961; Email: email@example.com
Media contact David Sampson Elsevier +1-215-239-3171 firstname.lastname@example.org
Press spacebar to pause and continue. Press esc to stop.